Back to Search
JOSEPH PREY, PHARMD
PHARMD
Pharmacist
NPI: 1306569975Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
84262(CA)
Research & Publications (6)
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.
PMID 19235592·Cancer Invest·2009
3-trial
A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors.
PMID 17989978·Cancer Chemother Pharmacol·2008
3-trial
Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent.
PMID 17239826·Biochem Pharmacol·2007
7-preclinical
A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors.
PMID 16489079·Clin Cancer Res·2006
3-trial
Pharmacokinetic measurements of IDN 5390 using electrospray ionization tandem mass spectrometry: structure characterization and quantification in dog plasma.
PMID 16299696·Rapid Commun Mass Spectrom·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7915 FLORENCE AVE
DOWNEY, CA 90240 - Phone
- (562) 927-4747
Quick Facts
- NPI
- 1306569975
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile